Semaglutide is a GLP-1 receptor agonist that has revolutionized weight loss research.

How Semaglutide Works

Semaglutide mimics GLP-1, reducing appetite, slowing gastric emptying, and improving insulin sensitivity.

Research Results

• 15-17% average weight loss
• Reduced cardiovascular events
• Decreased food cravings

Dosing Titration

Start 0.25mg weekly, increase to 2.4mg over months to minimize GI effects.

Side Effects

Nausea and constipation improve with proper titration.

Research peptides are NOT equivalent to FDA-approved Ozempic/Wegovy.